Arca Biopharma | ABIO - Interest Expense On Debt


Arca Biopharma reported $4.6M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Amgen USD 95.64B 94.98B Jun/2026
Arca Biopharma USD 4.6M 4.1M Mar/2026
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 407M 4M Jun/2026
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cipla INR 170.3M 39M Jun/2026
Compugen USD 1.35M 399K Mar/2026
CSL USD 215M 111M Dec/2025
Cytokinetics USD 34.83M 1.5M Jun/2026
Daiichi Sankyo JPY 3.57B 1.4B Mar/2026
Gilead Sciences USD 247M 7M Jun/2026
GlaxoSmithKline GBP 121M 46M Jun/2026
Grifols EUR 156.07M 31.46M Sep/2025
Laboratory Of America USD 61.1M 6M Jun/2026
Myriad Genetics USD 4.4M 600K Dec/2025
Otsuka Holdings JPY 2.21B 866M Dec/2025
Pfizer USD 667M 4M Jun/2026
United Therapeutics USD 2.9M 200K Jun/2026